| No. (%) |
---|---|
Age (years) | |
 Median | 50.5 (IQR 41–57) |
Gender | |
 Male | 9 (69.2) |
 Female | 4 (30.8) |
ECOG PS | |
 One | 9 (69.2) |
 Two | 4 (30.8) |
Sidedness of the primary tumor | |
 Right | 3 (23.1) |
 Left | 10 (76.9) |
Number of organs involved | |
 Median | 1 |
 Range | (1–2) |
 One | 8 (61.5) |
 Greater than one | 5 (38.5) |
Site of metastasis | |
 Liver | 5 (38.5) |
 Lung | 1 (7.7) |
 LNs | 6 (46.2) |
 Peritoneum | 5 (38.5) |
KRAS gene mutation | |
 Mutant | 7 (53.8) |
 Wild-type | 5 (38.5) |
 Unknown | 1 (7.7) |
Best response to XELOXIRI/A | |
 CR | 1 (7.7) |
 PR | 10 (76.9) |
 SD | 2 (15.4) |
Surgical resection margin | Â |
 R0 | 10 (76.9) |
 R1 | 3 (23.1) |